Search PubMed⌕ Search

Biomedical subjects

J Pillich

Publications and source records attributed to J Pillich.

At least 37 records · Page 2Linked to original sources

Therapeutic possibilities in Pseudomonas infections.

Acute pseudomonas infections require treatment with antibiotics producing a bactericidal effect. The most useful are gentamicin, tobramycin, sisomicin and polymyxin B. In resistant strains, amikacin is indicated in addition. Carbenicillin, ticarcillin, carfenicillin or azocillin should never be given alone but in combination with some of the above preparations. Other drugs, such as chloramphenicol, tetracycline or streptomycin, though effective in vitro, should be avoided. Chemotherapy may be complemented by passive immunization either with hyperimmune specific gama globulin or hyperimmune plasma. A programmatic item of combined treatment is active immunization, especially with toxoid vaccine. Chronic processes are not, perhaps with the exception of urinary infections, suitable for antibiotic therapy. For this reason effective polyvalent vaccines should be developed from appropriate strains. It is now certain that in infections caused by mucous strains (most frequently encountered in cystic fibrosis) the vaccine should be prepared from these strains, since they have distinct functional and antigenic characteristics.

Acute Disease↗

[Contribution to the treatment of acute haematogenous anc chronic secondary osteomyelitis in children (author's transl)].

The possibility of utilizing antistaphylococcal vaccine and local phage lysate for complex therapy of chronic and acute haematogenous osteomyelitis in children is demonstrated on three clinical cases. The study reassurmes good experience with this therapy in adult patients with chronic osteomyelitis. The results obtained so far in children suggest that the application of antistaphylococcal vaccine and of local phage lysate positively influences the course of the osteomyelitic disease and reduces the number of relpases. In order to specify and intensify the clinical effect of the above mentioned preparations, this method is being employed in other cases of chronic and acute haematogenous osteomyelitis.

Acute Disease↗

Serological characterization of phages of coagulase-negative staphylococci.

Selected 22 phages of coagulase-negative staphylococci were tested against group-specific antisera for Staphylococcus aureus phages using a neutralization test. Fourteen of the tested phages were classified into the serological group B and one into the group F. All other phages were resistant to the antisera against S. aureus phages but cross-reacted with the antisera produced against themselves. Therefore they could be joined together into a new serological group of the staphylococcal phages.

Bacteriophage Typing↗

Electron microscopic morphology of phages of coagulase-negative staphylococci.

Nine phages of coagulase-negative staphylococci were studied carefully with regard to their electron microscopic morphology. Two different groups of phages were detected: the larger phages showed heads of 121 nm diameter on average and tails with 229 nm length and 23 nm width. The smaller phages were characterized with heads of about 76 nm diameter and tails of about 177 nm length and 13 nm width (negatively stained with KPT).

Coagulase↗

A proposal for further modification of the phage-typing system for coagulase-negative staphylococci.

Our phage-set, published in 1975 (6) was modified in that other staphylococcal hoststrains were found more suitable for the propagation. This new typing set of 15 phages should replace our old phage-sets. In comparing the phage-sets of Dr. Verhoef, Dr. Parisi and Dr. Blouse with our phages, the advantages of our new phage-set could be demonstrated. Lysogeny induction experiment with mitomycin C and UV-rays showed all staphylococcal host strains to be lysogenic. Conclusions of the studies performed were derived from and discussed.

Bacteriophage Typing↗

New bacteriophages of Staphylococcus epidermidis.

Fifty-six phages designated the U-series and 34 phages designated the Ph-series were carefully examined. The spectrum of activity was established for 183 strains of Staphylococcus epidermidis from different countries and for 258 strains of Staphylococcus aureus. All 90 phages were active against strains of both species, but some differences in sensitivity were noted. Sixteen of the 90 phages were selected for phage typing of S. epidermidis. With use of a routine test dilution of phage (the highest dilution that yields confluent lysis of the propagation strain), 71.6% of 183 coagulase-negative staphylococci tested were sensitive to the phages; 42 phage patterns were observed. The results indicate that phage typing of S. epidermidis can be recommended for epidemiological and ecological purposes.

Humans↗

[Chemical induction of lysogeny of Staphylococcus aureus (author's transl)].

Concerning the chemical induction of lysogeny of Staphylococcus aureus only little is known. Therefore, we performed induction experiments on 43 Staph, aureus strains using nine mutagenic substances and 15 chemotherapeutics. Only three of the nine mutagenic substances (beta-propiolacton, nitrosoguanidin and mitomycin C) and six of the 15 chemotherapeutics (penicillin G, ampicillin, cephalothin, nebacetin, novobiocin and nalidixie acid) showed inducing effects. Our results demonstrated furtheron that the lysogeny inducing ability is dependent on strains and substances used.

Anti-Bacterial Agents↗